Literature DB >> 2804891

Candida colonization and systemic infection in neutropenic patients. A retrospective study.

P Martino1, C Girmenia, M Venditti, A Micozzi, S Santilli, V L Burgio, F Mandelli.   

Abstract

The results of surveillance cultures in 424 neutropenic patients with hematologic malignancies were analyzed to evaluate the relationship between colonization and infection by Candida species. Eighteen (32%) of 56 patients with multiple noncontiguous colonized sites developed proven (13 cases) or probable (five cases) systemic candidiasis, versus two patients with proven candidiasis (1.2%) of 170 with one colonized site (P less than 0.00000001), and one patient with proven candidiasis (0.5%) of 198 without any evidence of Candida colonization (P less than 0.00000001). Twenty-two patients with multiple colonized sites who developed a febrile episode resistant to antibiotics were treated with empiric amphotericin B. Nine of 11 given empiric amphotericin B within day 6 survived versus three of 11 receiving antifungal therapy after day 6 (P = 0.014). The above data seem to justify further prospective studies on Candida colonization as indication to early antifungal therapy in febrile neutropenic patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2804891     DOI: 10.1002/1097-0142(19891115)64:10<2030::aid-cncr2820641011>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  22 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

Review 3.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 4.  Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care.

Authors:  J L Vincent; E Anaissie; H Bruining; W Demajo; M el-Ebiary; J Haber; Y Hiramatsu; G Nitenberg; P O Nyström; D Pittet; T Rogers; P Sandven; G Sganga; M D Schaller; J Solomkin
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

5.  The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project.

Authors:  Livio Pagano; Morena Caira; Annamaria Nosari; Chiara Cattaneo; Rosa Fanci; Alessandro Bonini; Nicola Vianelli; Maria Grazia Garzia; Mario Mancinelli; Maria Elena Tosti; Mario Tumbarello; Pierluigi Viale; Franco Aversa; Giuseppe Rossi
Journal:  Haematologica       Date:  2011-05-12       Impact factor: 9.941

6.  Prospective study of Candida species in patients at a comprehensive cancer center.

Authors:  A Safdar; V Chaturvedi; E W Cross; S Park; E M Bernard; D Armstrong; D S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

Review 7.  Practical modalities for prevention of fungal infections in cancer patients.

Authors:  B E De Pauw
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

Review 8.  Clinical and laboratory diagnosis of invasive candida infection in neutropenic patients.

Authors:  M Kalin; B Petrini
Journal:  Med Oncol       Date:  1996-12       Impact factor: 3.064

9.  Use of a monoclonal antibody in a dot immunobinding assay for detection of a circulating mannoprotein of Candida spp. in neutropenic patients with invasive candidiasis.

Authors:  F De Bernardis; C Girmenia; M Boccanera; D Adriani; P Martino; A Cassone
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

Review 10.  Diagnosis and treatment of invasive fungal infections in cancer patients.

Authors:  P Martino; C Girmenia
Journal:  Support Care Cancer       Date:  1993-09       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.